Ableitung von HBM-I-Werten für Perfluoroktansäure (PFOA) und Perfluoroktansulfonsäure (PFOS) – Stellungnahme der Kommission „Humanbiomonitoring“ des Umweltbundesamts

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

• Publication date

  2018-03-27

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s00103-018-2709-zPMID 29589091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HBM-II-Werte für Perfluoroctansäure (PFOA) und Perfluoroctansulfonsäure (PFOS) in Blutplasma – Stellungnahme der Kommission Human-Biomonitoring des Umweltbundesamtes

  2020cited by this paper
• ADONA and perfluoroalkylated substances in plasma samples of German blood donors living in South Germany.

  2017cited by this paper
• Issues raised by the reference doses for perfluorooctane sulfonate and perfluorooctanoic acid.

  2017cited by this paper
• Recent experimental results of effects of perfluoroalkyl substances in laboratory animals - Relation to current regulations and guidance values.

  2017cited by this paper
• Quantitative bias analysis of a reported association between perfluoroalkyl substances (PFAS) and endometriosis: The influence of oral contraceptive use.

  2017cited by this paper
• A Critical Review of Pharmacokinetic Modelling of PFOS and PFOA to Assist in Establishing HGBVs for these Chemicals

  2017cited by this paper
• [Not Available].

  2016cited by this paper
• Positive associations of serum perfluoroalkyl substances with uric acid and hyperuricemia in children from Taiwan.

  2016cited by this paper
• Association of perfluoroalkyl substances exposure in utero with reproductive hormone levels in cord blood in the Hokkaido Study on Environment and Children's Health.

  2016cited by this paper
• Perfluoroalkyl Substances, Sex Hormones, and Insulin-like Growth Factor-1 at 6–9 Years of Age: A Cross-Sectional Analysis within the C8 Health Project

  2016cited by this paper
• Perfluoroalkyl substances and endometriosis in US women in NHANES 2003-2006.

  2016cited by this paper
• A prospective study of prepregnancy serum concentrations of perfluorochemicals and the risk of gestational diabetes.

  2015cited by this paper
• Association of polyfluoroalkyl chemical exposure with serum lipids in children.

  2015cited by this paper
• Association between perfluoroalkyl substances and reproductive hormones in adolescents and young adults.

  2015cited by this paper
• Hazard assessment of fluorinated alternatives to long-chain perfluoroalkyl acids (PFAAs) and their precursors: status quo, ongoing challenges and possible solutions.

  2015cited by this paper
• Working Towards A Global Emission Inventory of PFASs: Focus on PFCAs – Status Quo and the Way Forward

  2015cited by this paper
• Associations of perfluorinated chemical serum concentrations and biomarkers of liver function and uric acid in the US population (NHANES), 2007-2010.

  2015cited by this paper
• Association between perfluoroalkyl acids and kidney function in a cross-sectional study of adolescents

  2015cited by this paper
• Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC study

  2015cited by this paper
• Temporal trends of perfluorooctanesulfonate isomer and enantiomer patterns in archived Swedish and American serum samples.

  2015cited by this paper
• Prenatal Exposure to Perfluoroalkyl Acids and Serum Testosterone Concentrations at 15 Years of Age in Female ALSPAC Study Participants

  2015cited by this paper
• Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: a case–control study

  2014cited by this paper
• The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Integration of Animal and Human Evidence for PFOA Effects on Fetal Growth

  2014cited by this paper
• The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Nonhuman Evidence for PFOA Effects on Fetal Growth

  2014cited by this paper
• Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.

  2014cited by this paper
• Prenatal exposure to endocrine disrupting chemicals in relation to thyroid hormone levels in infants – a Dutch prospective cohort study

  2014cited by this paper
• The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Human Evidence for PFOA Effects on Fetal Growth

  2014cited by this paper
• The association between PFOA, PFOS and serum lipid levels in adolescents.

  2014cited by this paper
• Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.

  2014cited by this paper
• Helsingør statement on poly- and perfluorinated alkyl substances (PFASs).

  2014cited by this paper
• Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.

  2014cited by this paper
• Global emission inventories for C4-C14 perfluoroalkyl carboxylic acid (PFCA) homologues from 1951 to 2030, Part I: production and emissions from quantifiable sources.

  2014cited by this paper
• Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011.

  2014cited by this paper
• Serum Perfluorooctanoic Acid and Perfluorooctane Sulfonate Concentrations in Relation to Birth Outcomes in the Mid-Ohio Valley, 2005–2010

  2013cited by this paper
• Exposure to Perfluoroalkyl Acids and Markers of Kidney Function among Children and Adolescents Living near a Chemical Plant

  2013cited by this paper
• Polyfluoroalkyl Chemicals and Menopause among Women 20–65 Years of Age (NHANES)

  2013cited by this paper
• Design, Methods, and Population for a Study of PFOA Health Effects among Highly Exposed Mid-Ohio Valley Community Residents and Workers

  2013cited by this paper
• Part I. A temporal study of PFCAs and their precursors in human plasma from two German cities 1982-2009.

  2013cited by this paper
• Grundsatzpapier zur Ableitung von HBM-Werten

  2013cited by this paper
• Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children

  2013cited by this paper
• Part II. A temporal study of PFOS and its precursors in human plasma from two German cities in 1982-2009.

  2013cited by this paper
• Reductions in Serum Lipids with a 4-year Decline in Serum Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid

  2013cited by this paper
• Long-term effects of prenatal exposure to perfluoroalkyl substances on female reproduction.

  2013cited by this paper
• Positive association between perfluoroalkyl chemicals and hyperuricemia in children.

  2013cited by this paper
• Dietary exposure to selected perfluoroalkyl acids (PFAAs) in four European regions

  2013cited by this paper
• Retrospective monitoring of perfluorocarboxylates and perfluorosulfonates in human plasma archived by the German Environmental Specimen Bank.

  2013cited by this paper
• Perfluorinated alkylated substances in vegetables collected in four European countries; occurrence and human exposure estimations

  2013cited by this paper
• Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood

  2013cited by this paper
• Occurrence of perfluoroalkyl substances (PFASs) in various food items of animal origin collected in four European countries

  2013cited by this paper
• Human exposure to fluorotelomer alcohols, perfluorooctane sulfonate and perfluorooctanoate via house dust in Bavaria, Germany.

  2013cited by this paper
• Perfluorinated compounds.

  2012cited by this paper
• Perfluorinated Compounds and Subfecundity in Pregnant Women

  2012cited by this paper
• Thyroid Function and Perfluoroalkyl Acids in Children Living Near a Chemical Plant

  2012cited by this paper
• Perfluorochemicals and Endometriosis: The ENDO Study

  2012cited by this paper
• Perfluorinated Compounds in Umbilical Cord Blood and Adverse Birth Outcomes

  2012cited by this paper
• Maternal Concentrations of Polyfluoroalkyl Compounds during Pregnancy and Fetal and Postnatal Growth in British Girls

  2012cited by this paper
• Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.

  2012cited by this paper
• Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature.

  2012cited by this paper
• Human biomonitoring of environmental chemicals--early results of the 2007-2009 Canadian Health Measures Survey for males and females.

  2012cited by this paper
• Perfluorooctanoic acid (PFOA) — main concerns and regulatory developments in Europe from an environmental point of view

  2012cited by this paper
• Implications of early menopause in women exposed to perfluorocarbons.

  2011cited by this paper
• Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with age of puberty among children living near a chemical plant.

  2011cited by this paper
• A temporal trend study (1972-2008) of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in pooled human milk samples from Stockholm, Sweden.

  2011cited by this paper
• Perfluoroalkyl compounds in dust from Asian, Australian, European, and North American homes and UK cars, classrooms, and offices.

  2011cited by this paper
• Perfluoroalkyl and Polyfluoroalkyl Substances in the Environment: Terminology, Classification, and Origins

  2011cited by this paper
• Perfluoroalkyl chemicals and elevated serum uric acid in US adults

  2011cited by this paper
• Effects of perfluorooctanesulfonate exposure on plasma lipid levels in the Inuit population of Nunavik (Northern Quebec).

  2010cited by this paper
• Perfluorinated substances in human food and other sources of human exposure.

  2010cited by this paper
• PFOS or PreFOS? Are perfluorooctane sulfonate precursors (PreFOS) important determinants of human and environmental perfluorooctane sulfonate (PFOS) exposure?

  2010cited by this paper
• Levels of perfluorinated compounds in food and dietary intake of PFOS and PFOA in the Netherlands.

  2010cited by this paper
• Two-year follow-up biomonitoring pilot study of residents' and controls' PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany.

  2010cited by this paper
• Association between Serum Perfluorooctanoic Acid (PFOA) and Thyroid Disease in the U.S. National Health and Nutrition Examination Survey

  2010cited by this paper
• Rate of Decline in Serum PFOA Concentrations after Granular Activated Carbon Filtration at Two Public Water Systems in Ohio and West Virginia

  2009cited by this paper
• Perfluoroalkyl Acids in Marine Organisms from Lake Shihwa, Korea

  2009cited by this paper
• Carryover of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) from Soil to Plants

  2009cited by this paper
• Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant.

  2009cited by this paper
• A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring.

  2009cited by this paper
• EU-wide survey of polar organic persistent pollutants in European river waters.

  2009cited by this paper
• Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice.

  2009cited by this paper
• Exposure to Polyfluoroalkyl Chemicals and Cholesterol, Body Weight, and Insulin Resistance in the General U.S. Population

  2009cited by this paper
• Maternal levels of perfluorinated chemicals and subfecundity.

  2009cited by this paper
• New POPs - The unique challenge of controlling PBDEs under the Stockholm Convention

  2009cited by this paper
• Draft toxicological profile for perfluoroalkyls

  2009cited by this paper
• [Reference values for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) in blood plasma].

  2009cited by this paper
• Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with Uric Acid among Adults with Elevated Community Exposure to PFOA

  2009cited by this paper
• Perfluorinated compounds--exposure assessment for the general population in Western countries.

  2009cited by this paper
• A first global production, emission, and environmental inventory for perfluorooctane sulfonate.

  2009influential reference
• Temporal trends of perfluoroalkyl compounds with isomer analysis in lake trout from Lake Ontario (1979-2004).

  2008cited by this paper
• Perfluorinated acids as novel chemical tracers of global circulation of ocean waters.

  2008cited by this paper
• Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate.

  2008cited by this paper
• Fractionation and bioaccumulation of perfluorooctane sulfonate (PFOS) isomers in a Lake Ontario food web.

  2008cited by this paper
• Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006.

  2008cited by this paper
• Correlations between Prenatal Exposure to Perfluorinated Chemicals and Reduced Fetal Growth

  2008cited by this paper
• Perfluorinated Compounds in River Water, River Sediment, Market Fish, and Wildlife Samples from Japan

  2007cited by this paper
• Cord Serum Concentrations of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate (PFOA) in Relation to Weight and Size at Birth

  2007cited by this paper
• Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers

  2007cited by this paper
• Analysis of per- and polyfluorinated alkyl substances in air samples from Northwest Europe.

  2007cited by this paper
• Perfluoroalkyl acids: a review of monitoring and toxicological findings.

  2007cited by this paper
• Perfluorinated Chemicals and Fetal Growth: A Study within the Danish National Birth Cohort

  2007cited by this paper
• A global mass balance analysis of the source of perfluorocarboxylic acids in the Arctic Ocean.

  2007cited by this paper

• Developmental exposure to perfluorooctane sulfonate(PFOS) impairs the endometrial receptivity

  2025cites this paper
• PFAS-Exposition in Deutschland: Soziale Ungleichheiten und Herausforderungen für die Erfassung besonders betroffener Gruppen

  2025cites this paper
• Monitoring of per- and polyfluoroalkyl substances (PFAS) in human blood samples collected in three regions with known PFAS releases in the environment and three control regions in South Germany

  2024cites this paper
• The Exposure Status of Environmental Chemicals in South Korea: The Korean National Environmental Health Survey 2018–2020

  2024cites this paper
• Adverse Effects of Perfluorooctane Sulfonate on the Liver and Relevant Mechanisms

  2022cites this paper
• Schadstoffe (Kontaminanten) und Rückstände in Muttermilch sowie in Säuglings- und Kindernahrung

  2022cites this paper
• Per- und polyfluorierte Alkylsubstanzen (PFAS) und Stillen: Nutzen-Risiken-Abwägungen

  2021cites this paper
• Argumentation Analysis of Risk Assessments: The Case of Perfluorooctanoic Acid

  2021influential citation
• Per- and Poly-fluoroalkyl Substances (PFAS) and Female Reproductive Outcomes: PFAS Elimination, Endocrine-Mediated Effects, and Disease.

  2021cites this paper
• Stellungnahme

  2021cites this paper
• Outcome of a public consultation on the draft risk assessment of perfluoroalkyl substances in food

  2020cites this paper
• Perfluorinated substances in the Flemish population (Belgium): Levels and determinants of variability in exposure.

  2020cites this paper
• HBM-II-Werte für Perfluoroctansäure (PFOA) und Perfluoroctansulfonsäure (PFOS) in Blutplasma – Stellungnahme der Kommission Human-Biomonitoring des Umweltbundesamtes

  2020cites this paper
• Per- and polyfluoroalkyl substances in blood plasma - Results of the German Environmental Survey for children and adolescents 2014-2017 (GerES V).

  2020cites this paper
• Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.

  2020cites this paper
• Risk to human health related to the presence of perfluoroalkyl substances in food

  2020cites this paper
• Spatial and temporal analyses of perfluorooctanoic acid in drinking water for external exposure assessment in the Ruhr metropolitan area, Germany

  2020cites this paper
• HBM-II values for perfluorooctanoic acid (PFOA) and perfluorooctane- sulfonic acid (PFOS) in blood plasma

  2020cites this paper
• Per- and polyfluoroalkyl substances (PFAS) in Australia: Current levels and estimated population reference values for selected compounds.

  2019cites this paper
• Biomonitoring of perfluorinated compounds in adults exposed to contaminated drinking water in the Veneto Region, Italy.

  2018cites this paper
• Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population

  2018cites this paper
• HBM-II values for perfluorooctanoic acid (PFOA) and perfluorooctane-sulfonic acid (PFOS) in blood plasma

  year unknowncites this paper